Citations

Mayo Clinic

Showing 10 of 108523 citations.

Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder
Fipps, David C. , Oesterle, Tyler , Kolla, Bhanu P, Fipps, David C , Oesterle, Tyler S , Kolla, Bhanu Prakash

Seminars in Neurology | June 7, 2024 | Volume: 44 | Issue: 04 | Pages: 441-451

10.1055/s-0044-1787571 | PMID 38848746 Get It

AbstractThe rates of opioid use and opioid related deaths are escalating in the United States. Despite this, evidence-based treatments for Opioid Use Disorder are underutilized. There are three medications FDA approved for treatment of Opioid Use Disorder: Methadone, Buprenorphine, and Naltrexone. This article reviews the history, criteria, and mechanisms associated with Opioid Use Disorder. Pertinent pharmacology considerations, treatment strategies, efficacy, safety, and challenges of Methadone, Buprenorphine, and Naltrexone are outlined. Lastly, a practical decision making algorithm is discussed to address pertinent psychiatric and medical comorbidities when prescribing pharmacology for Opioid Use Disorder.
Opioid-Associated Nervous System Injuries
Griffin, Kim, Stitt, Derek

Seminars in Neurology | June 7, 2024 | Volume: 44 | Issue: 04 | Pages: 452-458

10.1055/s-0044-1787545 | PMID 38848747 Get It

AbstractWith the rise of the opioid epidemic, the practicing neurologist must recognize the patterns of a growing number of opioid-associated neurological injuries. This is in addition to the classic toxidrome of miosis, altered mental status, and respiratory depression, which must never be overlooked, as it is reversible and potentially lifesaving. Several other idiosyncratic syndromes due to opioid-related nervous system insults are defined by their characteristic imaging findings and portend variable functional recovery. Opioid toxicity can not only lead to brain injury, but also spinal cord and, rarely, peripheral nerve injury. As several newer synthetic opioids are undetectable by most assays, a low threshold to suspect opioid exposure must be maintained.
Molecular Breast Imaging Biopsy with a Dual-Detector System
Hunt, Katie N. , Conners, Amy Lynn , Gray, Lacey R., Hruska, Carrie B. , O’Connor, Michael K. , Gray, Lacey, Hruska, Carrie B , O'Connor, Michael K

Radiology: Imaging Cancer | June 7, 2024 | Volume: 6 | Issue: 4 | Pages: No page available

10.1148/rycan.230186 | PMID 38847615 Get It

Counseling Women About Sexual Health Effects of Contraceptives
Vegunta, Suneela , Houston, Lisa E., Nicholson, Nicola A., David, Paru S.

Journal of Women's Health | June 7, 2024 | Volume: 33 | Issue: 11 | Pages: 1492-1500

10.1089/jwh.2023.0625 | PMID 38848279 Get It

Background: Choosing a contraceptive method is a pivotal decision for patients, whereas health care professionals (HCPs) face challenges in providing suitable recommendations. Adverse sexual effects often lead to dissatisfaction and discontinuation of contraceptives, underscoring the importance of thorough counseling and shared decision making between HCPs and patients. Objective: This article aims to investigate the relationship between contraceptive methods and female sexual function through a comprehensive review of available literature, emphasizing the importance of considering sexual health in contraceptive prescription and management. Methods: A systematic analysis of existing literature, incorporating studies utilizing validated sexual health questionnaires, was conducted to elucidate the intricate interplay between contraceptives and female sexual function. Results: The review encompasses various contraceptive methods, including combined hormonal contraceptives, progestin-only pills, depot medroxyprogesterone acetate, subdermal contraceptive implants, hormonal intrauterine devices, permanent sterilization, and barrier methods. Insights gleaned from the analysis shed light on the impact of these methods on female sexual health. Conclusion: Comprehensive understanding of the effects of contraceptives on female sexual function is crucial for both HCPs and patients. By integrating sexual health considerations into contraceptive surveillance, compliance can be improved, contraceptive efficacy optimized, and the risk of unwanted pregnancies minimized. This review underscores the significance of tailored counseling and shared decision making in contraceptive management, particularly for cisgender women.
Assessment of GFR in Patients with Cancer
Kitchlu, Abhijat , Silva, Verônica T. Costa e , Anand, Shuchi , Kala, Jaya , Abudayyeh, Ala , Inker, Lesley A. , Rosner, Mitchell H. , Karam, Sabine , Gudsoorkar, Prakash , Gupta, Shruti , Chen, Sheldon , Klomjit, Nattawat , Milanez, Tomaž, Motwani, Shveta S. , Khalid, Sheikh B. , Srinivasan, Vinay , Wanchoo, Rimda, Liu, Geoffrey , Geng, Yimin , Leung, Nelson , Motwani, Shveta S , Khalid, Sheikh B , Srinivasan, Vinay , Beumer, Jan Hendrik , Liu, Geoffrey , Orchanian-Cheff, Ani , Geng, Yimin , Herrmann, Sandra M , Gupta, Shruti , Kitchlu, Abhijat , Klomjit, Nattawat , Leung, Nelson , Tannir, Nizar , Herrmann, Sandra M.

Clinical Journal of the American Society of Nephrology | June 7, 2024 | Volume: 19 | Issue: 8 | Pages: 1061-1072

10.2215/cjn.0000000000000508 | PMID 38848131 Get It

Accurate assessment of GFR is crucial to guiding drug eligibility, dosing of systemic therapy, and minimizing the risks of both undertreatment and toxicity in patients with cancer. Up to 32% of patients with cancer have baseline CKD, and both malignancy and treatment may cause kidney injury and subsequent CKD. To date, there has been lack of guidance to standardize approaches to GFR estimation in the cancer population. In this two-part statement from the American Society of Onco-Nephrology, we present key messages for estimation of GFR in patients with cancer, including the choice of GFR estimating equation, use of race and body surface area adjustment, and anticancer drug dose-adjustment in the setting of CKD. These key messages are based on a systematic review of studies assessing GFR estimating equations using serum creatinine and cystatin C in patients with cancer, against a measured GFR comparator. The preponderance of current data involving validated GFR estimating equations involves the CKD Epidemiology Collaboration (CKD-EPI) equations, with 2508 patients in whom CKD-EPI using serum creatinine and cystatin C was assessed (eight studies) and 15,349 in whom CKD-EPI with serum creatinine was assessed (22 studies). The former may have improved performance metrics and be less susceptible to shortfalls of eGFR using serum creatinine alone. Since included studies were moderate quality or lower, the American Society of Onco-Nephrology Position Committee rated the certainty of evidence as low. Additional studies are needed to assess the accuracy of other validated eGFR equations in patients with cancer. Given the importance of accurate and timely eGFR assessment, we advocate for the use of validated GFR estimating equations incorporating both serum creatinine and cystatin C in patients with cancer. Measurement of GFR via exogenous filtration markers should be considered in patients with cancer for whom eGFR results in borderline eligibility for therapies or clinical trials.
Dietary intake, obesity, and physical activity in association with biliary tract cancer risk: Results from meta‐analyses of individual‐level data from prospective cohort studies of 723,326 adults
Gunchick, Valerie , Wen, Wanqing , Roberts, Lewis R. , Koshiol, Jill , Shu, Xiao‐Ou , Zheng, Wei , Koshiol, Jill , Shu, Xiao-Ou , Zheng, Wei , Roberts, Lewis R , Jia, Guochong

International Journal of Cancer | June 7, 2024 | Volume: 155 | Issue: 10 | Pages: 1721-1730

10.1002/ijc.35048 | PMID 38847561 Get It

AbstractBiliary tract cancer (BTC) is a rare and aggressive malignancy with increasing incidence. Most BTC cases are diagnosed with metastatic disease which carries a 5‐year survival rate of <5%. Physical activity, diet, and obesity might be associated with BTC risk, but studies have been limited particularly in African descendants. We addressed this knowledge gap by evaluating associations of BTC risk with obesity, physical activity, and dietary intakes in 723,326 adult participants in four cohort studies conducted in China, the United Kingdom, and the United States. Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) in each cohort; results were combined using meta‐analysis. All cohorts had ≥11 median follow‐up years with 839 incident BTC cases combined. BTC risk was positively associated with body mass index (BMI) and waist‐to‐hip ratio (WHR) whereas physical activity, fruit intake, and fish intake were inversely associated. HR and (95% CI) comparing BMI >35.0 to 18.5–24.9: 1.71 (1.26, 2.31), p‐trend <.0001; comparing BMI‐adjusted WHR top to bottom quartile: 1.20 (0.94, 1.53), p‐trend = .05; comparing ≥15–0 metabolic equivalent task‐hours/week 0.76 (0.61, 0.94), p‐trend = .009; comparing highest to lowest intake tertile for fruit and fish 0.79 (0.66, 0.95), p‐trend = .01; 0.82 (0.68, 0.98), p‐trend = .04, respectively. Associations were, in general, similar across ancestry groups. Our study provides strong evidence for important roles of obesity, diet, and physical activity in BTC etiology and stresses the need for lifestyle modification to combat the rising incidence of this fatal malignancy.
Case Reports: The Very Foundations of Medical Research
Rehfeldt, Kent H., Kountanis, Joanna A. , Sweitzer, BobbieJean , Luedi, Markus M. , Jeng, Christina L

A&A Practice | June 7, 2024 | Volume: 18 | Issue: 6 | Pages: e01791

10.1213/xaa.0000000000001791 | PMID 38847442 Get It

Microvascular reconstruction of midface osteoradionecrosis
Wax, Mark K. , Amin, Dev , Kane, Anne C. , Cannady, Steven B., Tasche, Kendall K. , DiLeo, Michael, Lander, Daniel P. , Pipkorn, Patrik , Sweeny, Larissa , Konuthula, Neeraja , Wax, Mark K , Kane, Anne C , Cannady, Steve B , Tasche, Kendall, Kejner, Alexandra E , Sweeny, Larissa , Jackson, Ryan S. , Curry, Joseph , Yang, Sara

Head & Neck | June 7, 2024 | Volume: 46 | Issue: 11 | Pages: 2824-2833

10.1002/hed.27824 | PMID 38845552 Get It

AbstractBackgroundHead and neck osteoradionecrosis (ORN) of the midface requiring free flap (FF) reconstruction is uncommon. This multi‐institutional study was designed to review outcomes for this rare patient population.MethodsRetrospective multi‐institutional review of FF reconstruction for midface ORN (2005–2022; n = 54).ResultsThe FF survival rate was 87% (n = 54). Patients were less likely to be tolerating a regular diet at 3 months postoperative if they had a preoperative history of prior head and surgery (80% vs. 95%; p = 0.02), a pathologic fracture (50% vs. 90%; p = 0.04), exposed bone intraorally (43% vs. 94%; p = 0.002), or a fistula (67% vs. 96%; p = 0.03). Mean albumin was higher in patients whose FF survived (3.6 ± 0.5 vs. 2.7 ± 1.4; p = 0.03). Patients with low prealbumin were more likely to undergo a hematoma evacuation (27% vs. 0%; p = 0.02).ConclusionIn this series of midface ORN requiring FF reconstruction preoperative nutritional status impacted postoperative complications. Preoperative occurrence of a fistula, pathologic fracture, and intraoral bone exposure correlated with decreased tolerance of a regular diet following reconstruction.
First Application of a Mixed Porcine–Human Repopulated Bioengineered Liver in a Preclinical Model of Post-Resection Liver Failure
Felgendreff, Philipp , Hosseiniasl, Seyed M. , Minshew, Anna, Amiot, Bruce , Wilken, Silvana, Ahmadzada, Boyukkhanim , Jalan‐Sakrikar, Nidhi , Engles, Noah G. , Halsten, Peggy, Mariakis, Kendra, Barry, John J., Riesgraf, Shawn A., Fecteau, Chris, Ross, Jeffrey , Nyberg, Scott L. , Hosseiniasl, Seyed Mohammad, Amiot, Bruce P, Sakrikar, Nidhi Jalan , Engles, Noah G , Nyberg, Scott L , Huebert, Robert C. , Barry, John, Ross, Jeffrey J.

Biomedicines | June 7, 2024 | Volume: 12 | Issue: 6 | Pages: 1272

10.3390/biomedicines12061272 | PMID 38927479 Get It

In this study, a mixed porcine–human bioengineered liver (MPH-BEL) was used in a preclinical setup of extracorporeal liver support devices as a treatment for a model of post-resection liver failure (PRLF). The potential for human clinical application is further illustrated by comparing the functional capacity of MPH-BEL grafts as assessed using this porcine PRLF model with fully human (FH-BEL) grafts which were perfused and assessed in vitro. BEL grafts were produced by reseeding liver scaffolds with HUVEC and primary porcine hepatocytes (MPH-BEL) or primary human hepatocytes (FH-BEL). PRLF was induced by performing an 85% liver resection in domestic white pigs and randomized into the following three groups 24 h after resection: standard medical therapy (SMT) alone, SMT + extracorporeal circuit (ECC), and SMT + MPH-BEL. The detoxification and metabolic functions of the MPH-BEL grafts were compared to FH-BEL grafts which were perfused in vitro. During the 24 h treatment interval, INR values normalized within 18 h in the MPH-BEL therapy group and urea synthesis increased as compared to the SMT and SMT + ECC control groups. The MPH-BEL treatment was associated with more rapid decline in hematocrit and platelet count compared to both control groups. Histological analysis demonstrated platelet sequestration in the MPH-BEL grafts, possibly related to immune activation. Significantly higher rates of ammonia clearance and metabolic function were observed in the FH-BEL grafts perfused in vitro than in the MPH-BEL grafts. The MPH-BEL treatment was associated with improved markers of liver function in PRLF. Further improvement in liver function in the BEL grafts was observed by seeding the biomatrix with human hepatocytes. Methods to reduce platelet sequestration within BEL grafts is an area of ongoing research.